Levin Andrew David
SEC insider (Form 3/4/5 filer). CIK 0001867539. Director at Vor Biopharma Inc. (VOR) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in WELLESLEY HILLS, MA.
Companies Levin Andrew David has filed insider reports for
- Vor Biopharma Inc. (VOR): Director
- Climb Bio, Inc. (CLYM): Director
Levin Andrew David
CIK: 0001867539
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 11, 2026VOR
Vor Biopharma Inc.
AwardDirectStock option (right to buy)
57.2K shares- - Jun 5, 2026CLYM
Climb Bio, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Dec 18, 2025VOR
Vor Biopharma Inc.
AwardDirectStock Option (Right to Buy)
3K shares- - Jun 4, 2025CLYM
Climb Bio, Inc.
AwardDirectStock Option (Right to Buy)
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  VOR Vor Biopharma Inc. | Award Stock option (right to buy) | 57,162 | - | - | Direct |
| Jun 5, 2026 |  CLYM Climb Bio, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Dec 18, 2025 | VOR Vor Biopharma Inc. | Award Stock Option (Right to Buy) | 3,000 | - | - | Direct |
| Jun 4, 2025 | CLYM Climb Bio, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
1-4 of 4 transactions